{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T19:37:53Z","timestamp":1725737873372},"publisher-location":"Boston, MA","reference-count":103,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781489916976"},{"type":"electronic","value":"9781489916952"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1986]]},"DOI":"10.1007\/978-1-4899-1695-2_2","type":"book-chapter","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T01:40:28Z","timestamp":1372470028000},"page":"39-60","source":"Crossref","is-referenced-by-count":0,"title":["Mechanisms of Depressant Drug Action\/Interaction"],"prefix":"10.1007","author":[{"given":"Eugene P.","family":"Schoener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2_CR1","unstructured":"Anonymous: Drug Interactions: General Mechanisms, in Evaluations of Drug Interactions. Washington, American Phamaceutical Association, 1976."},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/BF00562929","volume":"11","author":"J Kock-Weser","year":"1977","unstructured":"Kock-Weser J, Greenblatt DJ: Drug interactions in clinical perspective. Eur J Clin Pharmacol 11:405\u2013408, 1977.","journal-title":"Eur J Clin Pharmacol"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF00587771","volume":"297","author":"EJ Ariens","year":"1977","unstructured":"Ariens EJ, Simonis AM: Pharmacodynamic aspects of drug interactions. Naunyn-Schmiedebergs Arch Pharmacol 297:37\u201341, 1977.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.2165\/00003088-197803060-00002","volume":"3","author":"EM Sellers","year":"1978","unstructured":"Sellers EM, Holloway MR: Drug kinetics and alcohol ingestion. Clin Pharmacokin 3:440\u2013452, 1978.","journal-title":"Clin Pharmacokin"},{"key":"2_CR5","first-page":"113","volume-title":"Metabolic Effects of Alcohol","author":"EM Sellers","year":"1979","unstructured":"Sellers EM: Mechanisms of alcohol interactions with drugs, in Avogaro P, Sirotori CR, Tremoli E: Metabolic Effects of Alcohol. Amsterdam, Elsevier, 1979, pp 113\u2013118."},{"key":"2_CR6","first-page":"236","volume-title":"Drug Treatment, Principles and Practice of Clinical Pharmacology and Therapeutics","author":"LF Prescott","year":"1980","unstructured":"Prescott LF: Clinically important drug interactions, in Avery GS (ed): Drug Treatment, Principles and Practice of Clinical Pharmacology and Therapeutics, ed 2. Sydney, ADIS, 1980, pp 236\u2013262.","edition":"2"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0163-7258(81)90036-X","volume":"14","author":"E Mezey","year":"1981","unstructured":"Mezey E: Actions and interactions of ethanol with drugs on intermediary metabolism. Pharmacol Ther 14:411\u2013430, 1981.","journal-title":"Pharmacol Ther"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev.me.33.020182.000553","volume":"33","author":"AM Hoyumpa","year":"1982","unstructured":"Hoyumpa AM, Schenker S: Major drug interactions: Effect of liver disease, alcohol and malnutrition. Annu Rev Med 33:113\u2013149, 1982.","journal-title":"Annu Rev Med"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/00004714-198208000-00004","volume":"2","author":"EM Sellers","year":"1982","unstructured":"Sellers EM, Busto U: Benzodiazepines and ethanol: Assessment of the effects and consequences of psychotropic drug interactions. J Clin Psychopharmacol 2:249\u2013262, 1982.","journal-title":"J Clin Psychopharmacol"},{"key":"2_CR10","first-page":"237","volume-title":"Medical Disorders of Alcoholism","author":"CS Lieber","year":"1982","unstructured":"Lieber CS: Interaction of ethanol and drug metabolism, in Lieber CS (ed): Medical Disorders of Alcoholism. Philadelphia, Saunders, 1982, pp 237\u2013258."},{"key":"2_CR11","first-page":"214","volume":"17","author":"PF D\u2019Arey","year":"1982","unstructured":"D\u2019Arey PF, McElnay JC: Drug interactions involving the displacement of drugs from plasma protein and tissue binding sites. Pharmacol Ther 17:214\u2013220, 1982.","journal-title":"Pharmacol Ther"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0163-7258(82)90011-0","volume":"17","author":"JS Schou","year":"1982","unstructured":"Schou JS: Drug interactions at pharmacologically active receptor sites. Pharmacol Ther 17:199\u2013210, 1982.","journal-title":"Pharmacol Ther"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1528-1157.1982.tb06094.x","volume":"23","author":"CE Pippenger","year":"1982","unstructured":"Pippenger CE: An overview of antiepileptic drug interactions. Epilepsia 23:581\u2013586, 1982.","journal-title":"Epilepsia"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-1-4684-4436-0_9","volume-title":"Medical and Social Aspects of Alcohol Abuse","author":"RA Deitrich","year":"1983","unstructured":"Deitrich RA, Petersen DR: Interaction of ethanol with other drugs, in Tabakoff B, Sutker P, Randall CL: Medical and Social Aspects of Alcohol Abuse. New York, Plenum Press, 1983, p 247\u2013272."},{"key":"2_CR15","first-page":"583","volume":"24","author":"P Seeman","year":"1972","unstructured":"Seeman P: The membrane actions of anesthetics and tranquilizers. Pharmacol Rev 24:583\u2013655, 1972.","journal-title":"Pharmacol Rev"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0005-2736(72)90023-5","volume":"255","author":"S Roth","year":"1972","unstructured":"Roth S, Seeman P: The membrane concentrations of neutral and positive anesthetics fit the Meyer-Overton rule of anesthesia: Negative narcotics do not. Biochem Biophys Acta 255:207\u2013219, 1972.","journal-title":"Biochem Biophys Acta"},{"key":"2_CR17","first-page":"435","volume":"13","author":"JH Chin","year":"1977","unstructured":"Chin JH, Goldstein DB: Effects of low concentrations of ethanol on the fluidity of spin-labeled erythrocyte and brain membranes. Mol Pharmacol 13:435\u2013441, 1977.","journal-title":"Mol Pharmacol"},{"key":"2_CR18","first-page":"425","volume":"19","author":"JH Chin","year":"1981","unstructured":"Chin JH, Goldstein DB: Membrane-disordering action of ethanol: Variation with membrane cholesterol content and depth of the spin label probe. Mol Pharmacol 19:425\u2013431, 1981.","journal-title":"Mol Pharmacol"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/0005-2736(78)90204-3","volume":"513","author":"JH Chin","year":"1978","unstructured":"Chin JH, Parsons LM, Goldstein DB: Increased cholesterol content of Erythrocyte and brain membranes in ethanol tolerant mice. Biochem Biophys Acta 513:358\u2013363, 1978.","journal-title":"Biochem Biophys Acta"},{"key":"2_CR20","first-page":"694","volume":"21","author":"CK Daniels","year":"1982","unstructured":"Daniels CK, Goldstein DB: Movement of free cholesterol from lipoproteins or lipid vesicles into erythrocytes. Acceleration by ethanol in vitro. Mol Pharmacol 21:694\u2013700, 1982.","journal-title":"Mol Pharmacol"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1530-0277.1979.tb04768.x","volume":"3","author":"JM Littleton","year":"1979","unstructured":"Littleton JM, John GR, Grieve SJ: Alterations in phospholipid composition in ethanol tolerance and dependence. Alcoholism: Clin Exp Res 3:50\u201356, 1979.","journal-title":"Alcoholism: Clin Exp Res"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1016\/0006-2952(80)90016-7","volume":"29","author":"NM Lee","year":"1980","unstructured":"Lee NM, Friedman HJ, Loh HH: Effect of acute and chronic ethanol treatment on rat brain phospholipid. Biochem Pharmacol 29:2815\u20132818, 1980.","journal-title":"Biochem Pharmacol"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.167.3915.126-a","volume":"167","author":"VE Davis","year":"1970","unstructured":"Davis VE, Walsh MJ: Alcohol, amines and alkaloids: A possible biochemial basis for alcohol addiction. Science 167:1005\u20131007, 1970.","journal-title":"Science"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.167.3926.1749","volume":"167","author":"G Cohen","year":"1970","unstructured":"Cohen G, Collins M: Alkaloids from catecholamines in adrenal tissue. Possible role in alcoholism. Science 167:1749\u201351, 1970.","journal-title":"Science"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-12-108450-9.50018-5","volume-title":"Alcohol and Opiates: Neurochemical and Behavioral Mechanisms","author":"M Hirst","year":"1977","unstructured":"Hirst M, Hamilton MG, Marshall AM: Pharmacology of isoquinoline alkaloids and ethanol interactions, in Blum K (ed): Alcohol and Opiates: Neurochemical and Behavioral Mechanisms. New York, Academic Press, 1977, pp 167\u2013187."},{"key":"2_CR26","first-page":"401","volume":"174","author":"VE Davis","year":"1970","unstructured":"Davis VE, Walsh MJ, Yamanaka Y: Augmentation of alkaloid formation from dopamine by alcohol and acetaldehyde in vitro. J Pharmacol Exp Ther 174:401\u2013412, 1970.","journal-title":"J Pharmacol Exp Ther"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1126\/science.170.3962.1113","volume":"170","author":"MH Seevers","year":"1970","unstructured":"Seevers MH: Morphine and ethanol physical dependence: A critique of a hypothesis. Science 170:1113\u20131114, 1970.","journal-title":"Science"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0091-3057(77)90006-5","volume":"7","author":"CL Melchior","year":"1977","unstructured":"Melchior CL, Myers RD: Preference for alcohol evoked by tetrahydropapaveroline (THP) chronically infused in the cerebral ventricle of the rat. Pharmacol Biochem Behav 7:19\u201335, 1977.","journal-title":"Pharmacol Biochem Behav"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0091-3057(80)90083-0","volume":"13","author":"C Duncan","year":"1980","unstructured":"Duncan C, Dietrich RA: A critical evaluation of tetrahydroisoquinoline induced ethanol preference in rats. Pharmacol Biochem Behav 13:265\u2013281, 1980.","journal-title":"Pharmacol Biochem Behav"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4615-6525-3_1","volume-title":"The Biology of Alcoholism","author":"H Kalant","year":"1971","unstructured":"Kalant H: Absorption, diffusion, distribution and elimination of ethanol, in Kissin B, Begleiter H (eds): The Biology of Alcoholism. Plenum Press, New York, 1971, vol 1, pp 1\u201362."},{"key":"2_CR31","volume-title":"Blutalkalkohol. Die Wissenschaflichen Grundlagen der Beurteilung von Blutalkoholbefinden bei Strassen Verkehrsdelikten","author":"H Elbel","year":"1956","unstructured":"Elbel H, Schleyer F: Blutalkalkohol. Die Wissenschaflichen Grundlagen der Beurteilung von Blutalkoholbefinden bei Strassen Verkehrsdelikten, ed 2. Stuhtgart, George Thieme, 1956.","edition":"2"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1748-1716.1930.tb01425.x","volume":"60","author":"PI Tuovinen","year":"1930","unstructured":"Tuovinen PI: Uber den Alkoholgehalt des Blutes unter verscheidenen Bedingungen. Skand. Arch. Physiol. 60:1\u2013134, 1930.","journal-title":"Skand. Arch. Physiol."},{"key":"2_CR33","first-page":"474","volume":"41","author":"J Rauschke","year":"1952","unstructured":"Rauschke J: Uber die Blutalkoholkurve in Stadium der Resorption. Deut Z Ges Gericht Med 41:474\u2013479, 1952.","journal-title":"Deut Z Ges Gericht Med"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1748-1716.1940.tb00272.x","volume":"1","author":"SM Berggren","year":"1940","unstructured":"Berggren SM, Goldberg L: The absorption of ethyl alcohol from the gastrointestinal tract as a diffusion process. Acta Physiol Scand 1:246\u2013270, 1940.","journal-title":"Acta Physiol Scand"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1748-1716.1965.tb04198.x","volume":"64","author":"C Crone","year":"1965","unstructured":"Crone C: The permeability of brain capillaries to non-electrolytes. Acta Physiol Scand 64:407\u2013417, 1965.","journal-title":"Acta Physiol Scand"},{"key":"2_CR36","first-page":"1","volume-title":"Medical Disorders of Alcoholism","author":"CS Lieber","year":"1981","unstructured":"Lieber CS: Metabolism of ethanol, in Lieber CS: Medical Disorders of Alcoholism. Philadelphia, Saunders, 1981, pp 1\u201342."},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1530-0277.1977.tb05765.x","volume":"1","author":"KE Crow","year":"1977","unstructured":"Crow KE, Cornell NW, Veech RL: The rate of ethanol metabolism in isolated rat hepatocytes. Alcoholism: Clin Exp Res 1:43\u201347, 1977.","journal-title":"Alcoholism: Clin Exp Res"},{"key":"2_CR38","volume-title":"Alcoholism: Development, consequences and interventions","author":"MA Schuckit","year":"1977","unstructured":"Schuckit MA, Haglund RMJ: An overview of the etiological theories on alcoholism, in Estes NJ, Heinemann ME (eds): Alcoholism: Development, consequences and interventions. St. Louis, CV Mosby, 1977."},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1139\/v59-238","volume":"37","author":"BB Coldwell","year":"1959","unstructured":"Coldwell BB, Smith HW: Alcohol levels in body fluids after ingestion of distilled spirits. Can J Biochem 37:43\u201352, 1959.","journal-title":"Can J Biochem"},{"key":"2_CR40","first-page":"1","volume-title":"The benzodiazepines, from Molecular Biology to Clinical Practice","author":"LH Sternbach","year":"1983","unstructured":"Sternbach LH: The discovery of CNS active 1,4-benzodiazepines, in Costa E (ed): The benzodiazepines, from Molecular Biology to Clinical Practice. New York, Raven Press, 1983, pp 1\u20136."},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/0014-2999(69)90038-7","volume":"8","author":"KM Taylor","year":"1969","unstructured":"Taylor KM, Laverty R: The effect of chlordiazepoxide, diazepam and nitrazepam on cate-cholamine metabolism in regions of the rat brain. Eur J Pharmacol 8:296\u2013301, 1969.","journal-title":"Eur J Pharmacol"},{"key":"2_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1126\/science.177.4044.180","volume":"177","author":"CD Weise","year":"1972","unstructured":"Weise CD, Berger BD, Stein L: Benzodiazepines: Antianxiety reducing activity by reduction of serotonin turnover in the brain. Science 177:180\u2013183, 1972.","journal-title":"Science"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.176.4033.428","volume":"176","author":"B Beer","year":"1972","unstructured":"Beer B, Chasin M, Clody DE, et al.: Cyclic adenosine monophosphate Phosphodiesterase in brain: Effect on anxiety. Science 176:428\u2013430, 1972.","journal-title":"Science"},{"key":"2_CR44","first-page":"81","volume-title":"Mechanism of Action of Benzodiazepines","author":"SH Snyder","year":"1975","unstructured":"Snyder SH, Enna SJ: The role of central glycine receptors in the pharmacological actions of benzodiazepines, in Costa E, Greengard P (eds): Mechanism of Action of Benzodiazepines. New York, Raven Press, 1975, pp 81\u201391."},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0024-3205(75)90501-9","volume":"17","author":"E Costa","year":"1975","unstructured":"Costa E, Guidotti A, Mao CC, et al.: New concepts on the mechanism of action of benzodiazepines. Life Sci 17:167\u2013186, 1975.","journal-title":"Life Sci"},{"key":"2_CR46","first-page":"131","volume-title":"Mechanism of Action of Benzodiazepines","author":"W Haefely","year":"1975","unstructured":"Haefely W, Kulcsar A, Mohler H, et al.: Possible involvement of GABA in the central actions of benzodiazepines, in Costa E, Greengard P (eds): Mechanism of Action of Benzodiazepines. New York, Raven Press, 1975, pp 131\u2013151."},{"key":"2_CR47","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/266732a0","volume":"266","author":"RF Squires","year":"1977","unstructured":"Squires RF, Braestrup C: Benzodiazepine receptors in the brain. Nature 266:732\u2013734, 1977.","journal-title":"Nature"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1126\/science.918669","volume":"198","author":"H Mohler","year":"1977","unstructured":"Mohler H, Okada T: Benzodiazepine receptors: Demonstration in the central nervous system. Science 198:849\u2013851, 1977.","journal-title":"Science"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/0028-3908(83)90112-0","volume":"22","author":"RF Squires","year":"1983","unstructured":"Squires RF: Benzodiazepine receptor multiplicity. Neuropharmacology 22:1443\u20131450, 1983.","journal-title":"Neuropharmacology"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0028-3908(84)90064-9","volume":"23","author":"JG Richards","year":"1984","unstructured":"Richards JG, Mohler H: Benzodiazepine receptors. Neuropharmacology 23:233\u2013242, 1984.","journal-title":"Neuropharmacology"},{"key":"2_CR51","first-page":"244","volume-title":"Neuropharmacology of Central Nervous System and Behavioral Disorders","author":"RC Speth","year":"1980","unstructured":"Speth RC, Guidotti A, Yamamura HY: The pharmacology of benzodiazepines, in Palmer GC (ed): Neuropharmacology of Central Nervous System and Behavioral Disorders. New York, Academic Press, 1980, pp 244\u2013283."},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0028-3908(84)90063-7","volume":"23","author":"NG Bowery","year":"1984","unstructured":"Bowery NG, Price GW, Hudson AL, et al.: GABA receptor multiplicity. Visualization of different receptor types in the mammalian CNS. Neuropharmacology 23:219\u2013231, 1984.","journal-title":"Neuropharmacology"},{"key":"2_CR53","first-page":"213","volume":"16","author":"SM Paul","year":"1981","unstructured":"Paul SM, Marangos PJ, Skolnick P: The benzodiazepine-GABA-chloride ionophore receptor complex: Common site of minor tranquilizer action. Biol Psychiatry 16:213\u2013229, 1981.","journal-title":"Biol Psychiatry"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"7180","DOI":"10.1073\/pnas.78.11.7180","volume":"78","author":"RE Study","year":"1981","unstructured":"Study RE, Barker JL: Diazepam and pentobarbital: Fluctuation analysis reveals different mechanisms for potentiation of GABA responses in cultured control neurons. Proc Natl Acad Sci USA 78:7180\u20137184, 1981.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR55","first-page":"391","volume":"14","author":"MK Ticku","year":"1978","unstructured":"Ticku MK, Ban M, Olsen RW: Binding of [3H]-dihydropicrotoxinin, a gamma-aminobutyric acid synaptic antagonist, to rat brain membranes. Mol Pharmacol 14:391\u2013402, 1978.","journal-title":"Mol Pharmacol"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.pa.19.040179.002531","volume":"19","author":"E Costa","year":"1979","unstructured":"Costa E, Guidotti A: Molecular mechanisms in the receptor action of benzodiazepines. Annu Rev Pharmacol Toxicol 19:531\u2013545, 1979.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2_CR57","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0024-3205(82)90622-1","volume":"30","author":"K Matsumoto","year":"1982","unstructured":"Matsumoto K, Fukuda H: Stimulation and protective effects of benzodiazepines on GABA receptors labeled with [3H] muscimol. Life Sci 30:935\u2013943, 1982.","journal-title":"Life Sci"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/0014-2999(78)90152-8","volume":"50","author":"GJ Wastek","year":"1978","unstructured":"Wastek GJ, Speth RC, Reisine TD, et al.: The effect of gamma-aminobutyric acid on [3H] flunitrazepam binding in the rat brain. Eur J Pharmacol 50:445\u2013447, 1978.","journal-title":"Eur J Pharmacol"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/0006-2952(78)90051-5","volume":"27","author":"DW Gallager","year":"1978","unstructured":"Gallager DW, Thomas JW, Tallman JP: Effect of GABAergic drugs on benzodiazepine binding site sensitivity in rat cerebral cortex. Biochem Pharmacol 27:2745\u20132749, 1978.","journal-title":"Biochem Pharmacol"},{"key":"2_CR60","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0014-2999(79)90060-8","volume":"60","author":"P Supavilai","year":"1979","unstructured":"Supavilai P, Karobath M: Stimulation of benzodiazepine receptor by SQ 20009 is chloride dependent and piorotoxin-sensitive. Eur J Pharmacol 60:111\u2013113, 1979.","journal-title":"Eur J Pharmacol"},{"key":"2_CR61","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1073\/pnas.79.19.6084","volume":"79","author":"A Guidotti","year":"1982","unstructured":"Guidotti A, Konkel DR, Ebstein B, et al.: Isolation, characterization and purification to homogeneity of a rat brain protein (GABA-modulin). Proc Natl Acad Sci USA 79:6084\u20136088, 1982.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR62","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/0024-3205(78)90128-5","volume":"23","author":"P Skolnick","year":"1978","unstructured":"Skolnick P, Marangos PJ, Goodwin FK: Identification of inosine and hypoxanthine as endogenous inhibitors of [3H] diazepam binding in the central nervous system. Life Sci 23:1473\u20131480, 1978.","journal-title":"Life Sci"},{"key":"2_CR63","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1073\/pnas.76.2.977","volume":"76","author":"T Asano","year":"1979","unstructured":"Asano T, Spector S: Identification of inosine and hypoxanthine as endogenous ligands for the brain benzodiazepine binding sites. Proc Natl Acad Sci USA 76:977\u2013981, 1979.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR64","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/278563a0","volume":"278","author":"H Mohler","year":"1979","unstructured":"Mohler H, Polc P, Cumin R, et al.: Nicotinamide is a brain constituent with benzodiazepine-like action. Nature 278:563\u2013565, 1979.","journal-title":"Nature"},{"key":"2_CR65","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/0028-3908(83)90116-8","volume":"22","author":"E Costa","year":"1983","unstructured":"Costa E, Corda MG, Guidotti A: On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepine and beta carboline derivatives. Neuropharmacology 22:1481\u20131492, 1983.","journal-title":"Neuropharmacology"},{"key":"2_CR66","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/0028-3908(84)90061-3","volume":"23","author":"P Ferrero","year":"1984","unstructured":"Ferrero P, Guidotti A, Conti-Tronconi B, et al.: A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sites. Neuropharmacology 23:1359\u20131362, 1984.","journal-title":"Neuropharmacology"},{"key":"2_CR67","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/0028-3908(83)90120-X","volume":"22","author":"CA Boast","year":"1983","unstructured":"Boast CA, Bernard PS, Barbaz BS, et al.: The neuropharmacology of various diazepam antagonists. Neuropharmacology 22:1511\u20131521, 1983.","journal-title":"Neuropharmacology"},{"key":"2_CR68","first-page":"103","volume-title":"GABA and Benzodiazepine Receptors","author":"S Paul","year":"1981","unstructured":"Paul S, Marangos P, Brownstein M, et al.: Demonstration and characterization of an endogenous inhibitor of GABA-enhanced [3H]-diazepam binding from bovine cerebral cortex, in Costa E, Dichiara G, Gessa GL (eds): GABA and Benzodiazepine Receptors. New York, Raven Press, 1981, pp 103\u2013110."},{"key":"2_CR69","first-page":"137","volume-title":"The Benzodiazepines, from Molecular Biology to Clinical Practice","author":"W Haefely","year":"1983","unstructured":"Haefely W, Bonetti EP, Burkard WP, et al.: Benzodiazepine antagonists, in Costa E (ed): The Benzodiazepines, from Molecular Biology to Clinical Practice. New York, Raven Press, 1983, pp 137\u2013146."},{"key":"2_CR70","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/0028-3908(83)90113-2","volume":"22","author":"C Braestrup","year":"1983","unstructured":"Braestrup C, Nielsen M, Honore T, et al.: Benzodiazepine receptor ligands with positive and negative efficacy. Neuropharmacology 22:1451\u20131457, 1983.","journal-title":"Neuropharmacology"},{"key":"2_CR71","first-page":"139","volume-title":"Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology","author":"BA Weissman","year":"1983","unstructured":"Weissman BA, Cott J, Hommer D, et al.: Pharmacological, electrophysiological and neurochemical actions of the convulsant benzodiazepine RO-5-4864 (4\u2032-Chlordiazepam), in Biggio G, Costa E (eds): Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology. New York, Raven Press, 1983, pp 139\u2013151."},{"key":"2_CR72","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/0006-8993(80)90087-6","volume":"195","author":"JW Phillis","year":"1980","unstructured":"Phillis JW, Bender AS, Wu PH: Benzodiazepines inhibit adenosine uptake into rat brain synaptosomes. Brain Res 195:494\u2013498, 1980.","journal-title":"Brain Res"},{"key":"2_CR73","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0014-2999(75)90214-9","volume":"30","author":"JW Phillis","year":"1975","unstructured":"Phillis JW: A potent depressant action of adenine derivatives on cerebral cortical neurons. Eur J Pharmacol 30:125\u2013129, 1975.","journal-title":"Eur J Pharmacol"},{"key":"2_CR74","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0304-3940(81)90186-5","volume":"23","author":"GR Siggins","year":"1981","unstructured":"Siggins GR, Schubert P: Adenosine depression of hippocampal neurons in vitro: An intra-cellular study of dose dependent actions on synaptic and membrane potentials. Neurosci Lett 23:55\u201360, 1981.","journal-title":"Neurosci Lett"},{"key":"2_CR75","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1139\/y79-066","volume":"57","author":"JW Phillis","year":"1979","unstructured":"Phillis JW: Diazepam potentiation of purinergic depression of central neurons. Can J Physiol Pharmacol 57:432\u2013435, 1979.","journal-title":"Can J Physiol Pharmacol"},{"key":"2_CR76","first-page":"53","volume-title":"The Benzodiazepines","author":"MA Schwartz","year":"1973","unstructured":"Schwartz MA: Pathways of metabolism of the benzodiazepines, in Garattini S, Mussini E, Randall LO (eds): The Benzodiazepines. New York, Raven Press, 1973, p 53."},{"key":"2_CR77","first-page":"173","volume-title":"The Benzodiazepines, from Molecular Biology to Clinical Practice","author":"SA Kaplan","year":"1983","unstructured":"Kaplan SA, Jack ML: Metabolism of the benzodiazepines: Pharmacokinetic and pharma-codynamic considerations, in Costa E (ed): The Benzodiazepines, from Molecular Biology to Clinical Practice. New York, Raven Press, 1983, pp 173\u2013199."},{"key":"2_CR78","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2125.1981.tb01099.x","volume":"11","author":"DJ Greenblatt","year":"1981","unstructured":"Greenblatt DJ, Shader RI, Divoll M, et al.: Benzodiazepines: A summary of pharmacokinetic properties. Br J Clin Pharmacol 11:115\u2013165, 1981.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2_CR79","first-page":"16","volume":"40","author":"G Alvan","year":"1977","unstructured":"Alvan G, Jonsson M, Sundwall A, et al.: First pass conjugation and enterohepatic recycling of oxazepam in dogs: Intravenous tolerance of oxazepam in propylene glycol. Acta Pharmacol Toxicol 40 (suppl 1):16\u201327, 1977.","journal-title":"Acta Pharmacol Toxicol"},{"key":"2_CR80","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/bja\/44.8.803","volume":"44","author":"ES Baird","year":"1972","unstructured":"Baird ES, Hailey DM: Delayed recovery from a sedative: Correlation of the plasma levels of diazepam with clinical effects after oral and intravenous administration. Br J Anaesth 44:803\u2013808, 1972.","journal-title":"Br J Anaesth"},{"key":"2_CR81","first-page":"391","volume":"14","author":"MK Ticku","year":"1978","unstructured":"Ticku MK, Ban M, Olsen RW: Binding of [3H]-dihydropicrotoxinin, a gamma-aminobutyric acid synaptic antagonist, to rat brain membranes. Mol Pharmacol 14:391\u2013402, 1978.","journal-title":"Mol Pharmacol"},{"key":"2_CR82","first-page":"165","volume-title":"GABA Neurotransmitters","author":"RW Olsen","year":"1979","unstructured":"Olsen RW, Ticku MK, Greenlee D, et al.: GABA receptor and ionophore binding sites: Interactions with various drugs, in Krogsgaard-Larsen P, Scheel-Kruger J, Kofod M (eds): GABA Neurotransmitters. Copenhagen, Munksgaard, 1979, p 165."},{"key":"2_CR83","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0006-8993(75)90526-0","volume":"92","author":"JL Barker","year":"1975","unstructured":"Barker JL: CNS depressants: Effects on postsynaptic pharmacology. Brain Res 92:35\u201355, 1975.","journal-title":"Brain Res"},{"key":"2_CR84","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/258625a0","volume":"258","author":"RA Nicoll","year":"1975","unstructured":"Nicoll RA, Eccles JC, Oshima T, et al.: Prolongation of hippocampal inhibitor post-synaptic potentials by barbiturates. Nature 258:625\u2013627, 1975.","journal-title":"Nature"},{"key":"2_CR85","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/0006-8993(76)90977-X","volume":"114","author":"BR Ransom","year":"1976","unstructured":"Ransom BR, Barker JL: Pentobarbital selectively enhances GABA-mediated post-synaptic inhibition in tissue cultured mouse spinal neurons. Brain Res 114:530\u2013535, 1976.","journal-title":"Brain Res"},{"key":"2_CR86","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0006-8993(79)90826-6","volume":"167","author":"RL MacDonald","year":"1979","unstructured":"MacDonald RL, Barker JL: Enhancement of GABA-mediated postsynaptic inhibition in cultured mammalian spinal cord neurons: A common mode of anticonvulsant action. Brain Res 167:323\u2013336, 1979.","journal-title":"Brain Res"},{"key":"2_CR87","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0006-8993(81)91179-3","volume":"209","author":"DW Schulz","year":"1981","unstructured":"Schulz DW, MacDonald RL: Barbiturate enhancement of GABA-mediated inhibition and activation of chloride ion conductance: Correlation with anticonvulsant and anesthetic actions. Brain Res 209:177\u2013188, 1981.","journal-title":"Brain Res"},{"key":"2_CR88","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1111\/j.1528-1157.1982.tb06093.x","volume":"23","author":"RL MacDonald","year":"1982","unstructured":"MacDonald RL, McLean MJ: Cellular bases of barbiturate and phenytoin anticonvulsant drug action. Epilepsia 23:S7\u2013S81, 1982.","journal-title":"Epilepsia"},{"key":"2_CR89","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev.pa.21.040181.000503","volume":"21","author":"IK Ho","year":"1981","unstructured":"Ho IK, Harris RA: Mechanism of action of barbiturates. Annu Rev Pharmacol Toxicol 21:83\u2013111, 1981.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2_CR90","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev.pa.24.040184.000355","volume":"24","author":"DB Goldstein","year":"1984","unstructured":"Goldstein DB: Th effects of drugs on membrane fluidity. Annu Rev Pharmacol Toxicol 24:43\u201364, 1984.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2_CR91","first-page":"369","volume":"11","author":"MP Blaustein","year":"1975","unstructured":"Blaustein MP, Ector AC: Barbiturate inhibition of calcium uptake by depolarized nerve terminals in vitro. Mol Pharmacol 11:369\u2013378, 1975.","journal-title":"Mol Pharmacol"},{"key":"2_CR92","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1016\/0006-2952(79)90616-6","volume":"28","author":"WF Hood","year":"1979","unstructured":"Hood WF, Harris RA: Effects of pentobarbital, ethanol and morphine on subcellular localization of calcium and magnesium in brain. Biochem Pharmacol 28:3075\u20133080, 1979.","journal-title":"Biochem Pharmacol"},{"key":"2_CR93","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1085\/jgp.51.3.293","volume":"51","author":"MP Blaustein","year":"1968","unstructured":"Blaustein MP: Barbiturates block sodium and potassium conductance increases in voltage clamped lobster axons. J Gen Physiol 51:293\u2013307, 1968.","journal-title":"J Gen Physiol"},{"key":"2_CR94","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF00963802","volume":"4","author":"RWP Cutler","year":"1979","unstructured":"Cutler RWP, Young J: Effect of barbiturates on release of endogenous amino acids from rat cortex slices. Neurochem Res 4:319\u2013329, 1979.","journal-title":"Neurochem Res"},{"key":"2_CR95","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/0024-3205(79)90516-2","volume":"25","author":"MB Friedman","year":"1979","unstructured":"Friedman MB, Coleman R, Leslie SW: Barbiturate depression of calcium-mediated stimulus secretion coupling in synaptosomes: A species and strain comparison. Life Sci 25:735\u2013738, 1979.","journal-title":"Life Sci"},{"key":"2_CR96","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0304-3940(80)90305-5","volume":"18","author":"M Willow","year":"1980","unstructured":"Willow M, Johnston GAR: Enhancement of GABA binding by pentobarbitone. Neurosci Lett 18:323\u2013327, 1980.","journal-title":"Neurosci Lett"},{"key":"2_CR97","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1523\/JNEUROSCI.01-04-00364.1981","volume":"1","author":"M Willow","year":"1981","unstructured":"Willow M, Johnston GAR: Enhancement by anesthetic and convulsant barbiturates of GABA binding to rat brain synaptosomal membranes. J Neurosci 1:364\u2013367, 1981.","journal-title":"J Neurosci"},{"key":"2_CR98","doi-asserted-by":"publisher","first-page":"7468","DOI":"10.1073\/pnas.77.12.7468","volume":"77","author":"F Leeb-Lundberg","year":"1980","unstructured":"Leeb-Lundberg F, Snowman A, Olsen RW: Barbiturate receptors are coupled to benzodiazepine receptors. Proc Natl Acad Sci USA 77:7468\u20137472, 1980.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR99","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/0006-2952(81)90383-X","volume":"30","author":"MK Ticku","year":"1981","unstructured":"Ticku MK: Interaction of depressant, convulsant and anticonvulsants barbiturates with [3H]-diazepam binding site at benzodiazepine-GABA receptor-ionophore complex. Biochem Pharmacol 30:1573\u20131579, 1981.","journal-title":"Biochem Pharmacol"},{"key":"2_CR100","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00003088-197702020-00002","volume":"2","author":"DD Breimer","year":"1977","unstructured":"Breimer DD: Clinical pharmacokinetics of hypnotics. Clin Pharmacokinet 2:93\u2013109, 1977.","journal-title":"Clin Pharmacokinet"},{"key":"2_CR101","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/cpt1971125849","volume":"12","author":"SH Curry","year":"1971","unstructured":"Curry SH, Riddall D, Gordon JJ, et al.: Disposition of glutethimide in man. Clin Pharmacol Ther 12:849\u2013857, 1971.","journal-title":"Clin Pharmacol Ther"},{"key":"2_CR102","first-page":"322","volume":"222","author":"AF Delong","year":"1976","unstructured":"Delong AF, Smyth RD, Polk A, Nayak RK, Reavey-Cantwell NH: Blood levels of metha-qualone in man following chronic therapeutic doses. Arch Int Pharmacodyn Ther 222:322\u2013331, 1976.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"2_CR103","first-page":"71","volume":"5","author":"BK Tang","year":"1977","unstructured":"Tang BK, Inaba T, Kalow W: N-Hydroxylation of Pentobarbital in man. Drug Metab Dispos 5:71\u201374, 1977.","journal-title":"Drug Metab Dispos"}],"container-title":["Recent Developments in Alcoholism"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4899-1695-2_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T05:13:43Z","timestamp":1557897223000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4899-1695-2_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986]]},"ISBN":["9781489916976","9781489916952"],"references-count":103,"URL":"https:\/\/doi.org\/10.1007\/978-1-4899-1695-2_2","relation":{},"ISSN":["0738-422X"],"issn-type":[{"type":"print","value":"0738-422X"}],"subject":[],"published":{"date-parts":[[1986]]}}}